共 21 条
Solubility and stability of dalcetrapib in vehicles and biological media
被引:18
作者:

Gross, Guenter
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland

Tardio, Joseph
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland

Kuhlmann, Olaf
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland
机构:
[1] F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland
关键词:
Dalcetrapib;
Dalcetrapib solubility;
Dalcetrapib stability;
Biorelevant media;
Biological media;
Cholesteryl ester transfer protein (CETP);
DISSOLUTION;
EXPRESSION;
PLASMA;
DRUGS;
FOOD;
D O I:
10.1016/j.ijpharm.2012.07.071
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Dalcetrapib solubility was determined in aqueous and in non-aqueous vehicles and in biorelevant media. In a pure aqueous environment the solubility was low but could be increased by addition of surfactants or complexing agents. This was also reflected in the solubility seen in simulated gastrointestinal (GI) fluids, with almost no solubility in simulated gastric fluid, but reasonable solubilisation in simulated intestinal fluids containing lecithin and bile salt. Additionally, the stability of dalcetrapib was determined in simulated GI fluids with and without pancreatic lipase. In solutions without lipase, dalcetrapib was slowly hydrolysed, but in the presence of lipase the hydrolysis rate was significantly faster depending on pH and enzyme activity. In biological fluids, dissolved dalcetrapib appeared to behave similarly being rapidly hydrolysed in human intestinal fluids with a half-life below 20 s with no degradation observed in human gastric fluids at low pH. The results provide supportive evidence that absorption is higher under fed conditions and indicate lipase inhibitors might interfere with oral absorption of dalcetrapib. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 21 条
[11]
Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
[J].
Galia, E
;
Nicolaides, E
;
Hörter, D
;
Löbenberg, R
;
Reppas, C
;
Dressman, JB
.
PHARMACEUTICAL RESEARCH,
1998, 15 (05)
:698-705

Galia, E
论文数: 0 引用数: 0
h-index: 0
机构: Univ Frankfurt, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany

Nicolaides, E
论文数: 0 引用数: 0
h-index: 0
机构: Univ Frankfurt, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany

Hörter, D
论文数: 0 引用数: 0
h-index: 0
机构: Univ Frankfurt, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany

Löbenberg, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Frankfurt, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany

Reppas, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Frankfurt, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany

Dressman, JB
论文数: 0 引用数: 0
h-index: 0
机构: Univ Frankfurt, Inst Pharmazeut Technol, D-60439 Frankfurt, Germany
[12]
Determination of dalcetrapib by liquid chromatography-tandem mass spectrometry
[J].
Heinig, Katja
;
Bucheli, Franz
;
Kuhlmann, Olaf
;
Zell, Manfred
;
Paehler, Axel
;
Zwanziger, Elke
;
Gross, Guenter
;
Tardio, Joseph
;
Ishikawa, Tomohiro
;
Yamashita, Tomoko
.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,
2012, 66
:314-324

Heinig, Katja
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Bucheli, Franz
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Kuhlmann, Olaf
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Zell, Manfred
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Paehler, Axel
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Zwanziger, Elke
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Gross, Guenter
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Formulat Res, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Tardio, Joseph
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Formulat Res, CH-4002 Basel, Switzerland F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Ishikawa, Tomohiro
论文数: 0 引用数: 0
h-index: 0
机构:
Japan Tobacco Inc, Div Pharmaceut, Clin Res Planning Dept, Tokyo, Japan F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland

Yamashita, Tomoko
论文数: 0 引用数: 0
h-index: 0
机构:
Japan Tobacco Inc, Cent Pharmaceut Res Inst, Drug Metab & Pharmacokinet Res Labs, Osaka, Japan F Hoffmann La Roche & Co Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4002 Basel, Switzerland
[13]
Dalcetrapib pharmacokinetics and metabolism in the cynomolgus monkey
[J].
Kuhlmann, Olaf
;
Heinig, Katja
.
XENOBIOTICA,
2011, 41 (05)
:430-436

Kuhlmann, Olaf
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4070 Basel, Switzerland F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4070 Basel, Switzerland

Heinig, Katja
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4070 Basel, Switzerland F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Nonclin Drug Safety, CH-4070 Basel, Switzerland
[14]
Simultaneous determination of tiopronin and its metabolites in rat blood by LC-ESI-MS-MS using methyl acrylate for stabilization of thiol group
[J].
Matsuura, K
;
Murai, K
;
Fukano, Y
;
Takashina, H
.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,
2000, 22 (01)
:101-109

Matsuura, K
论文数: 0 引用数: 0
h-index: 0
机构:
Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan

Murai, K
论文数: 0 引用数: 0
h-index: 0
机构:
Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan

Fukano, Y
论文数: 0 引用数: 0
h-index: 0
机构:
Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan

Takashina, H
论文数: 0 引用数: 0
h-index: 0
机构:
Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan Santen Pharmaceut Co Ltd, Dev Res Div, Higashiyodogawa Ku, Osaka 5338651, Japan
[15]
Estimation of the increase in solubility of drugs as a function of bile salt concentration
[J].
Mithani, SD
;
Bakatselou, V
;
TenHoor, CN
;
Dressman, JB
.
PHARMACEUTICAL RESEARCH,
1996, 13 (01)
:163-167

Mithani, SD
论文数: 0 引用数: 0
h-index: 0
机构: JANSSEN PHARMACEUT,ATHENS,GREECE

Bakatselou, V
论文数: 0 引用数: 0
h-index: 0
机构: JANSSEN PHARMACEUT,ATHENS,GREECE

TenHoor, CN
论文数: 0 引用数: 0
h-index: 0
机构: JANSSEN PHARMACEUT,ATHENS,GREECE

Dressman, JB
论文数: 0 引用数: 0
h-index: 0
机构: JANSSEN PHARMACEUT,ATHENS,GREECE
[16]
The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids
[J].
Persson, EM
;
Gustafsson, AS
;
Carlsson, AS
;
Nilsson, RG
;
Knutson, L
;
Forsell, P
;
Hanisch, G
;
Lennernäs, H
;
Abrahamsson, B
.
PHARMACEUTICAL RESEARCH,
2005, 22 (12)
:2141-2151

Persson, EM
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Gustafsson, AS
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Carlsson, AS
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Nilsson, RG
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Knutson, L
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Forsell, P
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Hanisch, G
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Lennernäs, H
论文数: 0 引用数: 0
h-index: 0
机构: AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden

Abrahamsson, B
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden AstraZeneca R&D, Dept Preformulat & Biopharmaceut, S-43183 Molndal, Sweden
[17]
UPPER GASTROINTESTINAL PH IN 79 HEALTHY, ELDERLY, NORTH-AMERICAN MEN AND WOMEN
[J].
RUSSELL, TL
;
BERARDI, RR
;
BARNETT, JL
;
DERMENTZOGLOU, LC
;
JARVENPAA, KM
;
SCHMALTZ, SP
;
DRESSMAN, JB
.
PHARMACEUTICAL RESEARCH,
1993, 10 (02)
:187-196

RUSSELL, TL
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109

BERARDI, RR
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109

BARNETT, JL
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109

DERMENTZOGLOU, LC
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109

JARVENPAA, KM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109

SCHMALTZ, SP
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109

DRESSMAN, JB
论文数: 0 引用数: 0
h-index: 0
机构: UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109
[18]
Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
[J].
Schwartz, Gregory G.
;
Olsson, Anders G.
;
Ballantyne, Christie M.
;
Barter, Phillip J.
;
Holme, Ingar M.
;
Kallend, David
;
Leiter, Lawrence A.
;
Leitersdorf, Eran
;
McMurray, John J. V.
;
Shah, Prediman K.
;
Tardif, Jean-Claude
;
Chaitman, Bernard R.
;
Duttlinger-Maddux, Regina
;
Mathieson, John
.
AMERICAN HEART JOURNAL,
2009, 158 (06)
:896-U34

Schwartz, Gregory G.
论文数: 0 引用数: 0
h-index: 0
机构:
VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA
Univ Colorado, Denver, CO 80202 USA VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Olsson, Anders G.
论文数: 0 引用数: 0
h-index: 0
机构:
Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Ballantyne, Christie M.
论文数: 0 引用数: 0
h-index: 0
机构:
Baylor Coll Med, Houston, TX 77030 USA
Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Barter, Phillip J.
论文数: 0 引用数: 0
h-index: 0
机构:
Heart Res Inst, Sydney, NSW, Australia VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Holme, Ingar M.
论文数: 0 引用数: 0
h-index: 0
机构:
Oslo Univ Hosp, Oslo, Norway VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Kallend, David
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
F Hoffmann La Roche & Co Ltd, Nutley, NJ USA VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Leiter, Lawrence A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Leitersdorf, Eran
论文数: 0 引用数: 0
h-index: 0
机构:
Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

McMurray, John J. V.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8QQ, Lanark, Scotland VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Shah, Prediman K.
论文数: 0 引用数: 0
h-index: 0
机构: VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Tardif, Jean-Claude
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Chaitman, Bernard R.
论文数: 0 引用数: 0
h-index: 0
机构:
Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
St Louis Univ, St Louis, MO 63103 USA VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Duttlinger-Maddux, Regina
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
F Hoffmann La Roche & Co Ltd, Nutley, NJ USA VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA

Mathieson, John
论文数: 0 引用数: 0
h-index: 0
机构:
F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
F Hoffmann La Roche & Co Ltd, Nutley, NJ USA VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA
[19]
Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS
[J].
Takahashi, Makoto
;
Pang, Henrianna
;
Kawabata, Kiyoshi
;
Farid, Nagy A.
;
Kurihara, Atsushi
.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,
2008, 48 (04)
:1219-1224

Takahashi, Makoto
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

Pang, Henrianna
论文数: 0 引用数: 0
h-index: 0
机构:
NoAb BioDiscoveries Inc, Mississauga, ON L5N 8G4, Canada Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

Kawabata, Kiyoshi
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sonkyo RD ASSOCIE Co Ltd, Res Dept 2, Shinagawa Ku, Tokyo 1400001, Japan Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

Farid, Nagy A.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

Kurihara, Atsushi
论文数: 0 引用数: 0
h-index: 0
机构:
Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[20]
Characterization of the Expression and Activity of Carboxylesterases 1 and 2 from the Beagle Dog, Cynomolgus Monkey, and Human
[J].
Williams, Eric T.
;
Bacon, James A.
;
Bender, David M.
;
Lowinger, Jennifer J.
;
Guo, Wen-Kai
;
Ehsani, Mariam E.
;
Wang, Xiliang
;
Wang, He
;
Qian, Yue-Wei
;
Ruterbories, Kenneth J.
;
Wrighton, Steven A.
;
Perkins, Everett J.
.
DRUG METABOLISM AND DISPOSITION,
2011, 39 (12)
:2305-2313

Williams, Eric T.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Bacon, James A.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Bender, David M.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Chem, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Lowinger, Jennifer J.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Guo, Wen-Kai
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Ehsani, Mariam E.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Integrat Biol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Wang, Xiliang
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Integrat Biol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Wang, He
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Integrat Biol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Qian, Yue-Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Integrat Biol, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Ruterbories, Kenneth J.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Wrighton, Steven A.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA

Perkins, Everett J.
论文数: 0 引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA